抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Casirivimab
All
TD-VK565046_1.jpg
TD-VK565046_2.jpg
TD-VK565046_3.jpg
- Catalog： TD-VK565046
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： REGN-10933,REGN10933,CAS:2415933-42-3
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Casirivimab
| Catalog No. | TD-VK565046 |
|---|---|
| Species reactivity | SARS-CoV-2 (2019-nCoV) |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | IgG1, kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P0DTC2 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | REGN-10933,REGN10933,CAS:2415933-42-3 |
| Background | Casirivimab (REGN10933) is a human monoclonal antibody that targets the SARS-CoV-2 virus, which causes COVID-19. Casirivimab is ineffective against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (HY-P99342), which alters the lung response of K18-hACE2 mice to the SARS-CoV-2 δ variant, effectively reducing viral load and improving symptoms. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Casirivimab. |
|
|
Detects Recombinant SARS-CoV-2 Spike protein receptor binding domain (Cat No.:TD-VK565021) in indirect ELISA. |
|
|
SDS-PAGE for Research Grade Casirivimab. |